PMC:7696151 / 32735-33037 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"911","span":{"begin":95,"end":103},"obj":"Species"},{"id":"912","span":{"begin":170,"end":178},"obj":"Species"},{"id":"964","span":{"begin":32,"end":35},"obj":"Chemical"},{"id":"965","span":{"begin":56,"end":59},"obj":"Chemical"},{"id":"966","span":{"begin":136,"end":139},"obj":"Chemical"},{"id":"967","span":{"begin":156,"end":159},"obj":"Chemical"},{"id":"999","span":{"begin":226,"end":242},"obj":"Disease"}],"attributes":[{"id":"A911","pred":"tao:has_database_id","subj":"911","obj":"Tax:9606"},{"id":"A912","pred":"tao:has_database_id","subj":"912","obj":"Tax:9606"},{"id":"A964","pred":"tao:has_database_id","subj":"964","obj":"MESH:D006886"},{"id":"A965","pred":"tao:has_database_id","subj":"965","obj":"MESH:D017963"},{"id":"A966","pred":"tao:has_database_id","subj":"966","obj":"MESH:D006886"},{"id":"A967","pred":"tao:has_database_id","subj":"967","obj":"MESH:D017963"},{"id":"A999","pred":"tao:has_database_id","subj":"999","obj":"MESH:D008133"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"prolongation was increased when HCQ was associated with AZM, as demonstrated in a cohort of 84 patients who received 400 mg twice-daily HCQ plus 500 mg/day AZM. In these patients, on day 3.6 ± 1.6 of therapy, the EGC showed a QTc prolongation from a baseline average of 435 ± 24 ms (mean ± SD) to a max"}